Abstract
Human leptospirosis is considered as one of the most widespread and potentially fatal zoonotic diseases that causes high mortality and morbidity in the endemic regions of tropical and subtropical countries. The infection can arise from direct or indirect exposure of human through contaminated environment that contains leptospires or animal reservoirs that carry leptospires. The clinical manifestations during human leptospirosis ranges from asymptomatic, mild infections to severe and life-threatening complications involving multi-organ failures with kidneys, lungs and liver severely affected. Despite much efforts have been put in to unravel the pathogenesis during human leptospirosis, it remains obscure to which extent the host factors or the pathogen itself contribute towards the pathogenesis. Host innate immunity, especially, polymorphonuclear neutrophils and complement system are involved in the first line of defense during human leptospirosis. However, pathogenic Leptospira has acquired diverse evasion strategies to evade from host immunity and establish infection in infected hosts. Hence, in this review, we focus on organs pathology during human leptospiral infection and host evasion strategies employed by Leptospira. A profound understanding on leptospiral immunity and how Leptospira subvert the immune system may provide new insights on the development of therapeutic regimens against this species in future.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
Human leptospirosis is a neglected tropical disease which remains the cause of high mortality and morbidity seen in patients infected with spirochetes from the genus Leptospira. Human leptospirosis often occurs at tropical and subtropical regions where approximately 59,000 deaths and 1.03 million cases were recorded globally (Costa et al. 2015; Torgerson et al. 2015). The high incidence rate has no doubt imposed huge impact on health consequences and economic burden on both affected patients and countries, which requires attention worldwide to handle this infection.
Infection with Leptospira spp. can occur via direct or indirect exposure from animal reservoirs or contaminated environments to infected patients. For example, it can be transmitted directly through exposure of wounds with tissues or urine of infected animals, ingestion of foods and water contaminated with infected rats and inhalation of aerosols of contaminated fluids. Meanwhile, it can also be transmitted indirectly via the mucuos membranes (mouth, nose and eyes) with contaminated soil or water (Bharti et al. 2003; Palaniappan et al. 2007). Additionally, pathogenic Leptospira spp. are equipped with specific adaptions to enable their survival inside and outside the host and hence make them successful colonizer and invader in both environment and hosts (Levett 2001).
Host immunity, especially innate immunity is the first line of defense against pathogenic leptospires. However, pathogenic leptospires are highly resistant to killing by host immunity and thus resulted in clinical outcomes in varying degrees, ranging from mild symptoms to life-threatening illness. Patients infected with mild leptospirosis are usually presented with febrile and headache and resolved without complications. However, patients with severe leptospirosis could present with multiple organ failure and complications such as pulmonary hemorrhage, jaundice, renal impairment, or kidney failure (Levett 2001). The underlying pathogenesis under these circumstances remains obscure. However, possible explanations could be due to interplay between epidemiological conditions, pathogen virulence, and host susceptibility. Moreover, pathogenic Leptospiraspp. have adopted multiple evasion strategies to prevent evasion from host immunity and subsequently establish infection in infected hosts. Hence, in this review, we seek to dissect leptospiral pathogenesis and organ pathology during human leptospirosis and to provide an overview on the anti-leptospiral immunity via complement system and polymorphonuclear neutrophils (PMN). In addition, the evasion strategies recruited by pathogenic Leptospira on host complement system will be discussed. The understanding on the capability of pathogenic Leptospira to subvert from host immunity is valuable for diagnostic and prognostic applications in future.
Leptospiral Pathogenesis and Organ Pathology During Human Leptospirosis
Leptospira species are highly motile gram-negative bacteria which can be clustered into three major groups, i.e., group I (pathogenic), group II (intermediate pathogenic,) and non-pathogenic (saprophytes), based on molecular phylogenetic analysis of Leptospira 16S rRNA (Lehmann et al. 2014; Chin et al. 2018). Group I consists of nine pathogenic Leptospira species including L. santarosai, L. kirschneri, L. noguchii, L. alexendari, L. interrogans, L. alstoni, L. weilii, L. borgpetersenii, and L. kmetyi, which can be further differentiated into more than 250 different serotypes, and causing a wide spectrum of clinical manifestations ranging from mild to severe and fatal infections. Additionally, most of the severe infections are often caused by serovars belonging to L. noguchii, L. interrogans, and L. kirschneri, which are considered as evolutionarily related species (Brenner et al. 1999; Slack et al. 2009). Meanwhile, group II comprises of five intermediate pathogenic species including L. broomii, L. fainei, L. wolffii, L. licerasiae, and L. inadai. Infection caused by these species are usually mild, self-resolving, and without fatal complications (Schmid et al. 1986; Brenner et al. 1999; Petersen et al. 2001; Levett et al. 2006; Matthias et al. 2008; Slack et al. 2008). On the other hand, six saprophytic Leptospira species have been reported thus far, including L. terpstrae, L. yanagawae, L. meyeri, L. wobachii, L. vanthielii, and L. biflexa. These saprophytic species are harmless to human and reside freely in the environment (Brenner et al. 1999).
The establishment of infection by pathogenic Leptospira during human leptospirosis often results in invasion, colonization, dissemination, and extraction of host nutrients. In addition, the outcome of the leptospiral infection are also largely dependent on a few determinants such as inoculum size (Ganoza et al. 2006), host immunity (Chin et al. 2018), and the virulence factors expressed by pathogenic Leptospira (Thaipadungpanit et al. 2007). A myriad of studies have documented Leptospira virulence factors including leptospiral immunoglobulin-like (Lig) proteins, hemolysins, OmpA-like Loa22, lipopolysaccharides (LPS), outer membrane protein (OMPs)–like lipoprotein, phingomyelinases, and adhesion molecules (Ko et al. 2009; Adler et al. 2011; Wang et al. 2012; Narayanavari et al. 2012).
In the context of organs pathology during human leptospirosis, liver is one of the organs affected during leptospiral infection with the severity varying from mild to severe hepatic dysfunction (Gancheva 2009). Grossly, the liver is often enlarged and tender; however, deaths rarely occur due to hepatic failure ((Vijayachari et al. 2008). Meanwhile, the histopathological changes in liver autopsy of leptospirosis fatal cases vary from mild interstitial edema and vascular congestion to advanced degenerative changes (Arean 1962). In addition, distention of the space of Disse by clear fluid with mixtures of cells including mononuclear cells, lymphocytes, and councilman bodies were observed (Arean 1962). These findings could be explained by a recent animal study which documented the infiltration of leptospires in the Disse’s space and preferential attachment and invasion of leptospires in the perijunctional region between hepatocytes in a hamster model of Weil’s disease infected with L. interrogans strain K37 (Miyahara et al. 2014).
Jaundice, marked by hepatocytes dystrophy and necrotic changes, intrahepatic cholestasis, and elevations of bilirubin and transaminase, is a common feature during leptospirosis. Matiash (1999) reported that the incidence of jaundice was observed in a lesser extent in the early stage of leptospiral infection due to the absence of marked disturbances in the protein-synthetizing function of the liver and low enzymatic activity. However, at later stage of infection (2 to 3 weeks after exposure to leptospiral infection), jaundice with high bilirubinemia was observed. This could be due to toxic affliction of hepatocytes and advancing centrilobular cholestasis (Matiash 1999).
On the other hand, histological analysis of the liver infected with L. interrogans strain K37 in hamster model of Weil’s disease revealed that hyperpermeability of the liver vascular wall, dyscomplexation of the liver crosspieces together with inflow of bile to the sinusoidal capillaries, and interstitial edema were reported at different time intervals during a leptospiral infection. The authors suggested that major contributing factor towards the early damage in the liver could be due to toxic vascular affection of the microcirculatory bed by leptospires (Miyahara et al. 2014). The authors also postulate a novel pathogenicity of leptospires where pathogenic leptospires tend to invade and disrupt the intercellular junctions of host hepatocytes, resulting in leakage of the bile from bile canaliculi and jaundice formation (Miyahara et al. 2014).
Besides the liver, the lungs are extremely affected during leptospiral infection. Histologically, pulmonary congestion accompanied with hemorrhage is commonly seen in patients with leptospirosis. A study of fatal leptospirosis by Arean (1962) revealed that all 33 fatal cases showed pulmonary petechiae on the plural surfaces with 60% of patients having gross hemorrhage on the cut surfaces of the lung with hemorrhage found in intra-alveolar spaces and alveolar septa (Arean 1962). Another study by Nicodemo et al. (1997) on the lung tissue of 12 fatal cases revealed that pulmonary hemorrhage alone or the combination of pulmonary hemorrhage with gastrointestinal bleeding was the main cause of death seen in eight patients. On the other hand, the authors also reported that edema was observed in the intra-alveolar septa, accompanied with mild-to-moderate inflammatory infiltrates, predominant by lymphocytes, plasma cells and macrophages. Meanwhile, immunohistochemistry studies on pulmonary tissues showed the deposition of leptospires within macrophages and endothelial cells in septa and alveoli, where leptospires were found attached to capillary endothelial cells (Nicodemo et al. 1997; Silva et al. 2002). Besides that, hyaline membrane formation in the lung also provide an indicative of diffuse alveolar damage caused by leptospires (O’Neil et al. 1991; Kiatboonsri et al. 1995).
The underlying mechanism of lung pathogenesis is still poorly understood. At present, pathogenesis in lung could be due to a toxin-mediated mechanism and/or the host immune responses. Hemorrhage seen in lung tissues during leptospiral infection could be due to toxin secreted by leptospires which resulted in capillary vasculitis (Luks et al. 2003). On the other hand, the numbers of leptospires present in lung tissues are much lower than the liver and blood counts, indicating that pulmonary abnormalities could be due to the exposure of circulating toxin produced by leptospires from distant sites such as the liver (Bharti et al. 2003).
In the lung, Na+/K+ pump is crucial for its role in removing sodium from alveolar fluid for edema clearance and homeostatic regulation in order to maintain lung integrity (Sznajder et al. 1994; Sznajder 2001). Inhibition of the Na+/K+ pump may result in lung failure in severe leptospirosis cases (Vadász et al. 2005). The evidence of alteration of Na-K-2Cl (NKCC) co-transporter and epithelial sodium channel (ENac) in the lungs during leptospirosis was demonstrated in an animal model. This alteration resulted in the impairment of pulmonary function and consequently pulmonary damage. In the study, ENac expression was found to be reduced while the NKCC expression increased in pulmonary cells of hamsters infected with Leptospira (Andrade et al. 2007). Furthermore, numerous sources reported the involvement of cytokines, such as tumor necrosis factor-alpha (TNF-α) in decreasing ENac and interleukin 1 (IL-1) in increasing Na-K-2Cl co-transporter during leptospiral infection (Dagenais et al. 2004; Choi et al. 2007; Yamagata et al. 2009). Taken together, these findings suggest that cytokines could be involved in the modification of ion channels resulting in pulmonary damage.
Apart from that, Bernardi et al. (2012) investigated the involvement of immune receptors and intercellular and vascular cell adhesion molecules in the lungs of patients with pulmonary involvement. The authors reported the increase in the expression of the VCAM-1, ICAM-1, C3a receptor, and Toll-like receptor 2 on alveolar septa of patients who died from leptospirosis. The authors speculated that adhesion molecules and immune receptors participate in the phenomena leading to pulmonary hemorrhage in fatal leptospirosis. The expression of these complement receptors and adhesion molecules could promote leukocyte recruitments to infected tissues. On the other hand, mild inflammation on lung tissues was observed in most of the fatal cases. The authors postulated that besides classical inflammatory responses, thrombocytopenia could be another pathological mechanistic contributor towards hemorrhagic phenomena in severe pulmonary hemorrhagic syndrome (Bernardi et al. 2012).
The kidney is also a preference target during human leptospirosis, which could be due to the intrinsic renal-tropic homing ability of leptospires on the host (Haake and Levett 2015). Renal involvement during leptospirosis can vary from mild non-oliguric renal impairment to complete renal failure, a typical presentation of Weil’s syndrome. The major histological findings often involve tubular necrosis and interstitial nephritis. Arean (1962) reported that tubular damage includes necrosis and thinning of tubular epithelium, with tubular lumen distended with cellular debris and hyaline casts (Arean 1962). In the reservoir host, leptospires enter host via penetration of the capillary lumen and interstitial tissue which causes edema and cell infiltration. On the other hand, Leptospira (Leptospira canicola) can adhere to renal tubule and tubular lumen. Immunohistochemistry analysis showed that Leptospira canicola antigens are attached in the proximal tubule epithelium cells and appear as big extracellular clusters in the interstitium (Morrison and Wright 1976).
Two major factors contributing towards the pathogenesis of acute kidney injury (AKI) in leptospirosis are toxin-induced immune response and direct nephrotoxic action of pathogenic Leptospira through toxin productions (Barnett et al. 1999). Previous study has shown that acute interstitial nephritis (AIN) is the main factor leading to AKI in leptospirosis (Cerqueira et al. 2008). Acute interstitial nephritis (AIN) is triggered by the presence of leptospires in renal tissues and usually occurs after tubular damage. Arean (1962) documented that patients who died within the first week of illness displayed acute tubular necrosis and cellular swelling while those patients who died between 2 and 3 weeks of illness exhibited acute tubular necrosis (ATN) and interstitial edema. Patients who died after 3 weeks of illness presented with diffuse and severe interstitial nephritis (Arean 1962). Another study also reported on the incidence of ATN in 13/15 patients from Moldova (Covic et al. 2003). These findings suggested that ATN could be due to direct toxic effect of leptospiral components on tubular epithelial cells or indirectly due to inability to concentrate urine and ionic wasting defects resulting from hypovolemia, dehydration, and ischemia.
On the other hand, the outer membrane of Leptospira contain antigenic components including endotoxins, lipoproteins, peptidoglycans, and lipopolysaccharides which can contribute towards kidney injury, inflammation, and tubular dysfunction. Several Leptospira outer membrane proteins (OMPs) including lipopolysaccharide (LPS), lipoprotein (LipL41), and a porin (OmpL1) have been identified to be located in the interstitium and proximal tubules of infected hamsters challenged with host-derived Leptospira kirschneri (Barnett et al. 1999). The authors suggest that OMPs could have crucial roles in inducing and causing persistent leptospiral interstitial nephritis (Barnett et al. 1999). Meanwhile, Yang et al. (2002) demonstrated the role of Leptospira outer membrane protein, LipL32 in the pathogenesis of tubulointerstitial nephritis. In this study, the authors showed that LipL32 from pathogenic Leptospira shermani affects mouse proximal tubular cells directly and leads to the increase in gene expression of T cells (RANTES), monocyte chemotactic protein-1 (CCL2/MCP-1), tumor necrosis factor-alpha (TNF-α), and inducible nitric oxide synthase (iNOS). Further, induction of these genes could be responsible for cellular damage in renal tissue (Yang et al. 2002). Similarly, a recent study by Chang et al. (2016) also demonstrated the role of LipL32 in inducing inflammation and causing renal damage in zebrafish larvae infected with Leptospira santarosai serovar Shermani (Chang et al. 2016). On the other hand, Humphryes et al. (2014) reported that vaccination with LipL32 had improved kidney invasion in hamsters infected with Leptospira interrogans Serovar Canicola (Humphryes et al. 2014), indicating the undisputable role of LipL32 in renal pathology during leptospirosis. Besides LipL32, Abreu et al. (2017) reported that Lp25 protein expressed by pathogenic Leptospira spp. is associated with rhabdomyolysis-induced AKI in a guinea pig model of leptospirosis (Abreu et al. 2017).
Host Immune Evasion by Pathogenic Leptospira
Polymorphonuclear Neutrophils
Innate immunity is the frontline of host defense during leptospirosis. Under normal circumstances, leptospires can reach up to 106–107 organisms per gram (g) in the tissues or per milliliter (mL) of blood of infected hosts (Truccolo et al. 2001) where phagocytosis or complement system is involved in the killing of leptospires. However, there is a high possibility where leptospires can evade from host innate immune through complement killing or clearance by phagocytosis.
Neutrophils and macrophages are important effectors during phagocytosis. Earlier studies have reported that human polymorphonuclear neutrophils (PMN) are effective in killing non-pathogenic leptospires (L. biflexa sp.), but not to pathogenic leptospires (L. interrogans sp.) in non-immune cells (Cinco and Banfi 1983a, b; Wang et al. 1984). Meanwhile, Murgia et al. (2002) demonstrated that pathogenic strain (Leptospira interrogans strain Hardjoprajitno) and non-pathogenic strain (Leptospira biflexa strain Patoc1 (serovar Patoc)) can be destroyed through oxygen-dependent and oxygen-independent reactions aided by hydrogen peroxide (H2O2), with or without the presence of myeloperoxidase (MPO) (Murgia et al. 2002). Further, the authors also confirmed the leptospiracidal activity of H2O2 alone in other pathogenic strains including Wijmberg (serovar Copenhageni), 142 (serovar Icterohaemorrhagiae), and Ballico (serovar Australis). Moreover, in this study, the authors reported that non-pathogenic Leptospira biflexa strain Patoc1 is more prone to killing by H2O2 than pathogenic Leptospira strains (Murgia et al. 2002). Besides killing by H2O2, leptospires are susceptible to the cationic peptides of neutrophils in oxygen-independent killing. Cathelicidin-derived peptides from neutrophils displayed anti-leptospiral activity among different Leptospira strains (L. interrogans serovars and Leptospira biflexa) (Scocchi et al. 1993; Sambri et al. 2002). On the other hand, a recent study showed that neutrophil extracellular traps (NETs) is involved in host innate immunity towards Leptospira. The authors reported that Leptospira interrogans serovar Copenhageni strain Fiocruz L1-130 (LIC) triggers the release of DNA extracellular traps (NETs) and kills the leptospires through NETosis, a process where extrusion of the neutrophil DNA with bactericidal proteins results in trapping and/or killing of the pathogens. The authors suggest that these DNA traps are crucial in preventing the early leptospiral dissemination (Scharrig et al. 2015).
Taken together, neutrophils are playing crucial role in killing leptospires. However, current evidences showed that leptospires are scarcely phagocytosed and killing occurs only in the presence of specific antibodies. Furthermore, these findings as discussed above demonstrated that neutrophils are mostly effective against saprophytic leptospires rather than pathogenic leptospires, thus increasing the chances of pathogenic leptospires to evade from the host immune system and establish infection in infected hosts. The actual mechanism on how pathogenic Leptospira escaped from neutrophil killings remains largely unknown. Indeed, a recent study documented that pathogenic leptospires (L. interrogans serovar Copenhageni) are able to inhibit myeloperoxidase (MPO) activities (peroxidase and chlorination), without meddling with neutrophil degranulation. The authors further identified a putative virulence factor, LipL21 as a potent MPO inhibitor, and postulated a novel innate immune evasion mechanism for the survival of leptospires in the host (Vieira et al. 2018).
Complement System
Apart from phagocytosis, the invasivity of leptospires is more closely related to complement system. Complement system comprises of more than 50 receptors and plasma proteins and is crucial in innate immune defense. Complement system is imperative in conferring protection against foreign microbes due to its inflammatory, lytic, and opsonic activities (Bloom 2002). The functions of complement effectors arise from the activation of classical (CP), alternative (AP), and/or lectin (LP) pathways. The lectin (LP) and alternate (AP) pathways are involved in the host innate immunity while classical pathway (CP) is triggered by the presence of IgM or IgG specifically bound to antigens. Meanwhile, the alternate pathway is activated when the intra-chain thioester bond located in the C3 molecule is hydrolyzed. C3 molecule, being the main element of the complement cascade, will generate C3a and C3b (Zipfel et al. 2007a, b) where C3b attaches to microbial surfaces and behaves like an opsonin to enhance the recognition of microbes and phagocytosis by host immune phagocytic cells (van Lookeren Campagne et al. 2007). On the other hand, lectin pathway is triggered when lectins, including ficolins or mannose-binding lectin, attach to carbohydrate moieties found on the microbial surfaces (Fraga et al. 2016).
Host Complement Evasion by Pathogenic Leptospira
Johnson and his colleague first reported on the complement-mediated anti-leptospiral activity against different Leptospira serotypes by using serum from different mammals. In their studies, they found that non-pathogenic Leptospira are more susceptible to complement killing as compared to pathogenic Leptospira (Johnson and Muschel 1966). Similarly, Cinco and his co-worker also demonstrated the complement resistance mechanism within the Leptospira genus (Cinco and Banfi 1983a, b). The authors reported that pathogenic Leptospira strains (Leptospira interrogans) showed resistance towards complement killing, but non-pathogenic leptospires (Leptospira biflexa strains) were killed to various degrees, probably via direct activation of complement alternative pathway. These studies indicate that pathogenic Leptospira strains are resistant to complement killing. However, the underlying mechanism on how the pathogenic Leptospira escape from complement attack remains elusive.
It is not surprising that pathogenic microorganisms employ various strategies to avoid attack by antibody or complement in the host, including Leptospira. Apparently, pathogenic Leptospira strains are more resistant towards complement-mediated killing, while saprophyte Leptospira strains are more prone to serum killing (Meri et al. 2005a, b; Barbosa et al. 2009). However, there is lack of current evidence on the efficacy of complement killing on intermediate pathogenic leptospires, for example, Leptospira licerasiae. Figure 1 depicts an overview on the complement evasion strategies recruited by pathogenic Leptospira. These strategies include (i) capturing or mimicking host complement regulators, (ii) cleavage of complement proteins on the Leptospira surface via acquisition of host proteases, and (iii) inactivation of complement through secretion of proteases (Fraga et al. 2016). Additionally, these diverse mechanisms are also employed by other pathogens such as fungi, bacteria, and viruses to avoid complement attack (Zipfel et al. 2007a, b; Rooijakkers and van Strijp 2007; Lambris et al. 2008; Blom et al. 2009).
Capturing or Mimicking Host Complement Regulators
Meri et al. (2005a, b) had first reported the mechanism undertaken by pathogenic Leptospira in avoiding complement killing. In this study, the authors surmised that the resistance of Leptospira serum-intermediate and serum-resistant strains towards complement-mediated killing was associated with the binding capacity of Leptospira towards factor H and factor H–related protein 1 (FHR-1a and FHR-1b) in human serum. Factor H and factor H–related protein 1 (FHR-1) are alternative complement pathway regulators. These proteins have multiple functions where they (i) can be the cofactor for the cleavage of C3b by factor I, (ii) accelerate the degeneration of the C3-convertase C3bBb, and (iii) prevent the binding of factor B to C3b (Meri et al. 2005a, b).
The association of Leptospira surface proteins with human factor H have been elucidated, including outer membrane protein LenA (leptospiral endostatin–like protein A) and LenB (leptospiral endostatin–like protein B) (Barbosa et al. 2006; Verma et al. 2006). It is documented that LenA binds to both factor H (FH) and factor H–related protein 1 (FHR-1), whereas LenB is only associated with factor H (Verma et al. 2006; Stevenson et al. 2007). Further, genetic analysis on L. interrogans revealed five more lenA paralogs, which are lenB, lenC, lenD, lenE, and lenF. These Len proteins showed their capacities to bind with laminin and fibronectin (with the exception on LenA, which could only interact with laminin), where these bindings facilitate host colonization and invasion by pathogenic Leptospira (Stevenson et al. 2007). Meanwhile, in a review by Zipfel et al. (2007a, b), the authors surmised that pathogens can escape from complement attack by binding to other host molecules, such as fibrinogen, plasminogen, IgA, IgG, extracellular matrix components, and thrombin, which eventually contribute to tissue adhesion and degradation of host cells (Zipfel et al. 2007a, b). In this context, several Leptospira proteins are also shown to interact with host complement regulators, including Lsa23 (binds to FH and C4BP) (Siqueira et al. 2016), Lsa30 (binds to C4BP) (Souza et al. 2012), and elongation factor Tu (EF-TU) (binds to FH) (Wolff et al. 2013).
Meanwhile, Barbosa et al. (2009) reported that both serum-resistant and serum-intermediate pathogenic leptospires have the ability to bind to human C4BP, whereas serum-sensitive strain Patoc1 binds in negligible amounts (Barbosa et al. 2009). Human C4BP is the fluid phase inhibitor involved in the lectin and classical pathways. The surface-bound C4BP promotes the factor I–mediated cleavage of C4b, which could contribute towards complement resistance by leptospires. In a later year, the authors identified that leptospiral complement regulator-acquiring protein A (LcpA) is expressed by leptospiral strains which showed partially resistant towards complement-mediated killing. LcpA is surface-exposed and can bind to both soluble and purified C4BP from human serum. It remains functionally active when bound to LcpA and facilitates the cleavage of C4b by factor 1 (Barbosa et al. 2010). Recent study also showed that LcpA of pathogenic Leptospira spp. can bind to factor H (FH), vitronectin (Vn), and complement terminal pathway. Competitive binding assays revealed that interaction of LcpA with C4BP, Vn, and FH occurs through distinct sites. Vitronectin (Vn) is a glycoprotein involved in the regulation of complement terminal pathway through inhibition of C5b7 complex formation and C9 polymerization. Hence, binding of Vn to leptospiral surface can eventually assist Leptospira from complement attack. It also helps to protect Leptospira from lysis by impairing membrane attack complex (MAC) formation (Preissner and Seiffert 1998; da Silva et al. 2015).
On the other hand, leptospiral immunoglobulin (Ig)–like proteins (Lig proteins): LigA and LigB, are multiple proteins involved in the interaction with cell lines, extracellular matrix (ECM), and complement regulators in vitro. These proteins may have role in bacterial attachment to host tissues and colonization. As demonstrated by Castiblanco-Valencia et al. (2012), binding of recombinant LigA and LigB of pathogenic L. interrogans serovar Pomona strain Fromm to C4BP, FH, FHR-1, and FHL-1 can interfere and control all complement pathways. This cleavage is believed to circumvent complement attack by pathogenic Leptospira. Furthermore, the authors demonstrated that C4BP and FH do not compete each other to bind to Lig proteins, suggesting that C4BP and FH have different binding sites on these molecules but interacting with their targets simultaneously (Castiblanco-Valencia et al. 2012). A study by Choy (2012) revealed that multiple activities of LigB enhances the virulence of L. interrogans. The author also demonstrated that both classical and alternative pathways are inhibited by LigB in hemolytic assays with erythrocytes. Further, the author reported that expression of LigB confers protection in saprophyte Leptospira biflexa and deduced that resistance of ligB-transformed L. biflexa towards complement killing could be due to the acquisition of FH and C3b by these bacteria (Choy 2012). These findings are further consolidated through a study by Castiblanco-Valencia et al. (2016) where resistance of saprophyte L. biflexa towards serum killing is greatly enhanced by the expression of both ligA and ligB genes, with a reduction in the membrane attack complex (MAC) deposition on lig-transformed L. biflexa as compared to the wild-type strain (Castiblanco-Valencia et al. 2016).
Pathogenic Leptospira spp. are also shown to block terminal pathway of the complement system to evade innate immunity. A study by Siqueira et al. (2017) demonstrated the ability of pathogenic, virulent strain L. interrogans L1-130 in binding to the immobilized human C8. Additionally, the authors also showed that virulent strain of L. biflexa was more competently interacting with C8 and C9 than the saprophyte L. biflexa strains, at physiological concentration (50 μg/mL). The authors reported that a novel leptospiral adhesion, Lsa23, could be responsible for the interaction between pathogenic Leptospira and C8 and C9 terminal complement components and further suggest that inhibiting the complement terminal pathway could be one of the strategy employed by pathogenic leptospires to evade host innate immunity (Siqueira et al. 2017).
Cleavage of Complement Proteins on the Leptospira Surface via Acquisition of Host Proteases
Vieira et al. (2009) discovered that Leptospira species could bind to human plasminogen (PLG) and generate plasmin (PLA) on its outer surface in the presence of urokinase-type plasminogen activator (uPA) (Vieira et al. 2009; Verma et al. 2010). The authors reported that PLG binding on the pathogenic Leptospira outer surface followed by activation of PLA leads to fibronectin degradation, which could explain the leptospiral invasiveness in hosts. Previous studies also reported that plasmin could degrade important biological substrates such as fibrinogen, ECM proteins, and human IgG and cleave immobilized IgG in physiological conditions (Harpel et al. 1989; Barthel et al. 2012). In addition, plasmin can interfere with C3b and lead to cleavage of this central complement protein. Hence, the ability of Leptospira to bind to human plasmin is a typical example on how pathogenic Leptospira can evade from complement attack through enzymatic degradation. Moreover, Vieira and his co-workers (Vieira et al. 2010) also found that pathogenic Leptopsira express multiple PLG-binding proteins. Eight proteins from PLG-binding receptors for Leptospira interrogans were identified and characterized, including the major outer protein, LipL32 (one of the key virulence factors of Leptospira). The binding/activation of PLG on the pathogenic Leptopsira surface proteins helps the bacteria to overcome tissue barriers, which in turn facilitate invasion and colonization of mammalian tissues. Furthermore, since PLG formation is occurring on Leptospira surface, it does increase the pathogenic Leptospira survival upon infection and creates an opportunity to modulate innate host immunity through protease-associated activity (Vieira et al. 2010).
Meanwhile, Vieira and his co-workers (Vieira et al. 2011) demonstrated that the association between plasmin (PLA) activity and Leptospira outer surface in bracket (pathogenic Leptospira interrogans) could result in host immune evasion and increase the survival of Leptospira. The authors demonstrated that bacteria-associated PLA can reduce C3b and IgG depositions on leptospiral surface, probably through degradation which diminishes the opsonization process. The authors speculated that the decrease in the opsonization process through PLA generation could be one of the crucial strategies for leptospires to escape and survive from host immune attack. These findings greatly enhance our understanding on leptospiral pathogenesis as well as leptospiral-host interaction. Furthermore, the survival of L. interrogans serovar Pomona in human serum was enhanced when bound to plasmin, which indicates the prominent role of plasmin in complement resistance (Vieira et al. 2011). Besides that, a numbers of Leptospira membrane proteins have also been reported as PLG ligands, including LigA and LigB (Castiblanco-Valencia et al. 2016), EF-Tu (Wolff et al. 2013), and Lsa23 (Siqueira et al. 2016), where interaction of these proteins with PLG causes the cleavage of C3b, C4b, and/or C5.
Inactivation of Complement Proteins Through Secretion of Leptospiral Proteases
Secretion of proteases by pathogenic Leptospira spp. will directly inactivate complement. Fraga et al. (2013) demonstrated that culture of pathogenic Leptospira can directly inhibit all three complement pathways, classical, alternative, and lectin pathways, through leptospiral proteases secretion. The authors postulated that inhibition of all three complement pathways were contributed by metalloproteases, a protease from thermolysin, which is found exclusively in Leptospira pathogenic species. Metalloproteases targets central complement protein C3, a key factor involved in the amplification of the complement cascade. Hence, degradation and cleavage of C3 will result in the functional inactivation of complement which consequently attenuated the host immune response towards Leptospira (Fraga et al. 2013). Furthermore, the inhibition of complement activation by thermolysin is further substantiated by findings from Amamura et al. (2017). The authors demonstrated the capability of thermolysin to inhibit membrane attack complex (MAC), through direct inhibition on MAC proteins C6–C9 (Amamura et al. 2017). Thus, it is plausible that secretion of proteases by pathogenic Leptospira helps in the evasion from complement system. Understanding the interlink between Leptospira proteases and inhibition of complement system activation can aid us in attaining more holistic views and for better designation of therapeutic regimens in the future to control this zoonotic disease.
Conclusion
Human leptospirosis remains one of the zoonotic diseases that causes high mortality and morbidity worldwide. Despite much effort have been put in, the underlying mechanism of the pathogenesis remains poorly understood. Much effort are needed to unravel the mechanisms of pathogenesis in the target organs during infection. On the other hand, Leptospira, being a highly invasive bacterium, employs diverse strategies to subvert host immunity to establish infection and invade target organs in the host. Identification of Leptospira putative virulence factors that interfere with host immune evasion could be potential therapeutic or vaccine candidates for better management of human leptospirosis in the future.
References
Abreu PA, Seguro AC, Canale D, da Silva AM, Do RB Matos L, Gotti TB, Monaris D, de Jesus DA, Vasconcellos SA, de Brito T, Magaldi AJ (2017) Lp25 membrane protein from pathogenic Leptospira spp. is associated with rhabdomyolysis and oliguric acute kidney injury in a guinea pig model of leptospirosis. PLoS Negl Trop Dis 11:e0005615
Adler B, Lo M, Seemann T, Murray GL (2011) Pathogenesis of leptospirosis: the influence of genomics. Vet Microbiol 153:73–81
Amamura TA, Fraga TR, Vasconcellos SA, Barbosa AS, Isaac L (2017) Pathogenic Leptospira secreted proteases target the membrane attack complex: a potential role for thermolysin in complement inhibition. Front Microbiol 8:958
Andrade L, Rodrigues AC Jr, Sanches TR (2007) Leptospirosis leads to dysregulation of sodium transporters in the kidney and lung. Am J Physiol Renal Physiol 292:F586–F592
Arean VM (1962) The pathologic anatomy and pathogenesis of fatal human leptospirosis (Weil’s disease). Am J Pathol 40:393–423
Barbosa AS, Abreu PA, Neves FO, Atzingen MV, Watanabe MM, Vieira ML, Morais ZM, Vasconcellos SA, Nascimento AL (2006) A newly identified leptospiral adhesin mediates attachment to laminin. Infect Immun 74:6356–6364
Barbosa AS, Abreu PA, Vasconcellos SA, Morais ZM, Gonçales AP, Silva AS, Daha MR, Isaac L (2009) Immune evasion of Leptospira species by acquisition of human complement regulator C4BP. Infect Immun 77:1137–1143
Barbosa AS, Monaris D, Silva LB, Morais ZM, Vasconcellos SA, Cianciarullo AM, Isaac L, Abreu PA (2010) Functional characterization of LcpA, a surface-exposed protein of Leptospira spp. that binds the human complement regulator C4BP. Infect Immun 78:3207–3216
Barnett JK, Barnett D, Bolin CA, Summers TA, Wagar EA, Cheville NF, Hartskeerl RA, Haake DA (1999) Expression and distribution of leptospiral outer membrane components during renal infection of hamsters. Infect Immun 67:853–861
Barthel D, Schindler S, Zipfel PF (2012) Plasminogen is a complement inhibitor. J Biol Chem 287:18831–18842
Bernardi FD, Ctenas B, da Silva LF, Nicodemo AC, Saldiva PH, Dolhnikoff M, Mauad T (2012) Immune receptors and adhesion molecules in human pulmonary leptospirosis. Hum Pathol 43:1601–1610
Bharti AR, Nally JE, Ricaldi JN, Matthias MA, Diaz MM, Lovett MA, Levett PN, Gilman RH, Willig MR, Gotuzzo E, Vinetz JM (2003) Leptospirosis: a zoonotic disease of global importance. Lancet Infect Dis 3:757–771
Blom AM, Hallstrom T, Riesbeck K (2009) Complement evasion strategies of pathogens acquisition of inhibitors and beyond. Mol Immunol 46:2808e17
Bloom AM (2002) Structural and functional studies of complement inhibitor C4b binding protein. Biochem Soc Trans 30:978–982
Brenner DJ, Kaufmann AF, Sulzer KR, Steigerwalt AG, Rogers FC, Weyant RS (1999) Further determination of DNA relatedness between serogroups and serovars in the family Leptospiraceae with a proposal for Leptospira alexanderi sp. nov. and four new Leptospira genomospecies. Int J Syst Evol Microbiol 49:839–858
Castiblanco-Valencia MM, Fraga TR, Silva LB, Monaris D, Abreu PA, Strobel S, Józsi M, Isaac L, Barbosa AS (2012) Leptospiral immunoglobulin-like proteins interact with human complement regulators factor H, FHL-1, FHR-1, and C4BP. J Infect Dis 205:995–1004
Castiblanco-Valencia MM, Fraga TR, Pagotto AH, de Toledo Serrano SM, Abreu PA, Barbosa AS, Isaac L (2016) Plasmin cleaves fibrinogen and the human complement proteins C3b and C5 in the presence of Leptospira interrogans proteins: a new role of LigA and LigB in invasion and complement immune evasion. Immunobiology 221:679–689
Cerqueira TB, Athanazio DA, Spichler AS, Seguro AC (2008) Renal involvement in leptospirosis – new insights into pathophysiology and treatment. Braz J Infect Dis 12:248–252
Chang MY, Cheng YC, Hsu SH, Ma TL, Chou LF, Hsu HH, Tian YC, Chen YC, Sun YJ, Hung CC, Pan RL (2016) Leptospiral outer membrane protein LipL32 induces inflammation and kidney injury in zebrafish larvae. Sci Rep 6:27838
Chin VK, Lee TY, Lim WF, Wan Shahriman YWY, Syafinaz AN, Zamberi S, Maha A (2018) Leptospirosis in human: biomarkers in host immune responses. Microbiol Res 207:108–115
Choi JY, Choi YS, Kim SJ, Son EJ, Choi HS, Yoon JH (2007) Interleukin-1beta suppresses epithelial sodium channel beta-subunit expression and ENaC-dependent fluid absorption in human middle ear epithelial cells. Eur J Pharmacol 567:19–25
Choy HA (2012) Multiple activities of LigB potentiate virulence of Leptospira interrogans: inhibition of alternative and classical pathways of complement. PLoS One 7:e41566
Cinco M, Banfi E (1983a) Activation and bactericidal activity of complement by leptospires. Zentralbl Bakteriol Mikrobiol Hyg A 1:261–265
Cinco M, Banfi E (1983b) Interactions between human polymorphonuclear leukocytes and one strain of pathogenic Leptospira (L. interrogans sp.) and one of saprophytic Leptospira (L. biflexa sp.). FEMS Microbiol Lett 9:51–54
Costa F, Hagan JE, Calcagno J, Kane M, Torgerson P, Martinez-Silveira MS, Stein C, Abela-Ridder B, Ko AI (2015) Global morbidity and mortality of leptospirosis: a systematic review. PLoS Negl Trop Dis 9:e0003898
Covic A, Goldsmith DJ, Gusbeth-Tatomir P, Seica A, Covic M (2003) A retrospective 5-year study in Moldova of acute renal failure due to leptospirosis: 58 cases and a review of the literature. Nephrol Dial Transplant 18:1128–1134
da Silva LB, Miragaia LS, Breda LC, Abe CM, Schmidt MC, Moro AM, Monaris D, Conde JN, Józsi M, Isaac L, Abreu PA (2015) Pathogenic Leptospira species acquire factor H and vitronectin via the surface protein LcpA. Infect Immun 83:888–897
Dagenais A, Frechette R, Yamagata Y, Yamagata T, Carmel JF, Clermont ME, Brochiero E, Massé C, Berthiaume Y (2004) Downregulation of ENaC activity and expression by TNF-alpha in alveolar epithelial cells. Am J Physiol Lung Cell Mol Physiol 286:L301–L311
Fraga TR, Courrol DD, Castiblanco-Valencia MM, Hirata IY, Vasconcellos SA, Juliano L, Barbosa AS, Isaac L (2013) Immune evasion by pathogenic Leptospira strains: the secretion of proteases that directly cleave complement proteins. J Infect Dis 209:876–886
Fraga TR, Isaac L, Barbosa AS (2016) Complement evasion by pathogenic Leptospira. Front Immunol 7:623
Gancheva GI (2009) Liver involvement in leptospirosis. Population 2006:8
Ganoza CA, Matthias MA, Collins-Richards D, Brouwer KC, Cunningham CB, Segura ER, Gilman RH, Gotuzzo E, Vinetz JM (2006) Determining risk for severe leptospirosis by molecular analysis of environmental surface waters for pathogenic Leptospira. PLoS Med 3:e308
Haake DA, Levett PN (2015) Leptospirosis in humans. In: Leptospira and leptospirosis. Springer, Berlin, Heidelberg, pp 65–97
Harpel PC, Sullivan R, Chang TS (1989) Binding and activation of plasminogen on immobilized immunoglobulin G. Identification of the plasmin-derived fab as the plasminogen-binding fragment. J Biol Chem 264:616e24
Humphryes PC, Weeks ME, AbuOun M, Thomson G, Núñez A, Coldham NG (2014) Vaccination with leptospiral outer membrane lipoprotein LipL32 reduces kidney invasion of Leptospira interrogans serovar Canicola in hamsters. Clin Vaccine Immunol 12:CVI-00719
Johnson RC, Muschel LH (1966) Antileptospiral activity of serum I. Normal and Immune Serum. J Bacteriol 91:1403–1409
Kiatboonsri S, Vathesatogit P, Charoenpan P (1995) Adult respiratory distress syndrome in Thai medical patients. Southeast Asian J Trop Med Public Health 26:774–780
Ko AI, Goarant C, Picardeau M (2009) Leptospira: the dawn of the molecular genetics era for an emerging zoonotic pathogen. Nat Rev Microbiol 7:736–747
Lambris JD, Ricklin D, Geisbrecht BV (2008) Complement evasion by human pathogens. Nat Rev Microbiol 6:132e42
Lehmann JS, Matthias MA, Vinetz JM, Fouts DE (2014) Leptospiral pathogenomics. Pathogens 3:280–308
Levett PN (2001) Leptospirosis. Clin Microbiol Rev 14:296–326
Levett PN, Morey RE, Galloway RL, Steigerwalt AG (2006) Leptospira broomii sp. nov., isolated from humans with leptospirosis. Int J Syst Evol Microbiol 56:671–673
Luks AM, Lakshminarayanan S, Hirschmann JV (2003) Leptospirosis presenting as diffuse alveolar hemorrhage: case report and literature review. Chest 123:639–643
Matiash VI (1999) The clinical aspects of acute liver failure in leptospirosis. Lik Sprava 5:43–46
Matthias MA, Ricaldi JN, Cespedes M, Diaz MM, Galloway RL, Saito M, Steigerwalt AG, Patra KP, Ore CV, Gotuzzo E, Gilman RH (2008) Human leptospirosis caused by a new, antigenically unique Leptospira associated with a Rattus species reservoir in the Peruvian Amazon. PLoS Negl Trop Dis 2:e213
Meri T, Murgia R, Stefanel P (2005a) Regulation of complement activation at the C3-level by serum resistant leptospires. Microb Pathog 39:139–147
Meri T, Murgia R, Stefanel P, Meri S, Cinco M (2005b) Regulation of complement activation at the C3-level by serum resistant leptospires. Microb Pathog 39:139–147
Miyahara S, Saito M, Kanemaru T, Villanueva SY, Gloriani NG, Yoshida SI (2014) Destruction of the hepatocyte junction by intercellular invasion of Leptospira causes jaundice in a hamster model of Weil’s disease. Int J Exp Pathol 95:271–281
Morrison WI, Wright NG (1976) Canine leptospirosis: an immunopathological study of interstitial nephritis due to Leptospira canicola. J Pathol 120:83–89
Murgia R, Garcia R, Cinco M (2002) Leptospires are killed in vitro by both oxygen-dependent and-independent reactions. Infect Immun 70:7172–7175
Narayanavari SA, Sritharan M, Haake DA, Matsunaga J (2012) Multiple leptospiral sphingomyelinases (or are there?). Microbiology 158:1137–1146
Nicodemo AC, Duarte MI, Alves VA, Takakura CF, Santos RT, Nicodemo EL (1997) Lung lesions in human leptospirosis: microscopic, immunohistochemical, and ultrastructural features related to thrombocytopenia. Am J Trop Med Hyg 56:181–187
O’Neil KM, Rickman LS, Lazarus AA (1991) Pulmonary manifestations of leptospirosis. Rev Infect Dis 13:705–709
Palaniappan RU, Ramanujam S, Chang YF (2007) Leptospirosis: pathogenesis, immunity, and diagnosis. Curr Opin Infect Dis 20:284–292
Petersen AM, Boye K, Blom J, Schlichting P, Krogfelt KA (2001) First isolation of leptospira fainei serovar hurstbridge from two human patients with Weil’s syndrome. J Med Microbiol 50:96–100
Preissner KT, Seiffert D (1998) Role of vitronectin and its receptors in haemostasis and vascular remodeling. Thromb Res 89:1–21
Rooijakkers SH, van Strijp JA (2007) Bacterial complement evasion. Mol Immunol 44:23e32
Sambri V, Marangoni A, Giacani L, Gennaro R, Murgia R, Cevenini R, Cinco M (2002) Comparative in vitro activity of five cathelicidin-derived synthetic peptides against Leptospira, Borrelia and Treponema pallidum. J Antimicrob Chemother 50:895–902
Scharrig E, Carestia A, Ferrer MF, Cédola M, Pretre G, Drut R, Picardeau M, Schattner M, Gómez RM (2015) Neutrophil extracellular traps are involved in the innate immune response to infection with Leptospira. PLoS Negl Trop Dis 9:e0003927
Schmid GP, Steere AC, Kornblatt AN, Kaufmann AF, Moss CW, Johnson RC, Hovind-Hougen K, Brenner DJ (1986) Newly recognized Leptospira species (Leptospira inadai serovar Lyme) isolated from human skin. J Clin Microbiol 24:484–486
Scocchi M, Romeo D, Cinco M (1993) Antimicrobial activity of two bactenecins against spirochetes. Infect Immun 61:3081–3083
Silva JJ, Dalston MO, Carvalho JE, Setúbal S, Oliveira JM, Pereira MM (2002) Clinicopathological and immunohistochemical features of the severe pulmonary form of leptospirosis. Rev Soc Bras Med Trop 35:395–399
Siqueira GH, Atzingen MV, de Souza GO, Vasconcellos SA, Nascimento AL (2016) Leptospira interrogans Lsa23 protein recruits plasminogen, factor H and C4BP from normal human serum and mediates C3b and C4b degradation. Microbiology 162:295–308
Siqueira GH, de Souza GO, Heinemann MB, Vasconcellos SA, Nascimento AL (2017) The role of Lsa23 to mediate the interaction of Leptospira interrogans with the terminal complement components pathway. Microb Pathog 112:182–189
Slack AT, Kalambaheti T, Symonds ML, Dohnt MF, Galloway RL, Steigerwalt AG, Chaicumpa W, Bunyaraksyotin G, Craig S, Harrower BJ, Smythe LD (2008) Leptospira wolffii sp. nov., isolated from a human with suspected leptospirosis in Thailand. Int J Syst Evol Microbiol 58:2305–2308
Slack AT, Khairani-Bejo S, Symonds ML, Dohnt MF, Galloway RL, Steigerwalt AG, Bahaman AR, Craig S, Harrower BJ, Smythe LD (2009) Leptospira kmetyi sp. nov., isolated from an environmental source in Malaysia. Int J Syst Evol Microbiol 59:705–708
Souza NM, Vieira ML, Alves IJ, de Morais ZM, Vasconcellos SA, Nascimento AL (2012) Lsa30, a novel adhesin of Leptospira interrogans binds human plasminogen and the complement regulator C4bp. Microb Pathog 53:125–134
Stevenson B, Choy HA, Pinne M, Rotondi ML, Miller MC, DeMoll E, Kraiczy P, Cooley AE, Creamer TP, Suchard MA, Brissette CA (2007) Leptospira interrogans endostatin-like outer membrane proteins bind host fibronectin, laminin and regulators of complement. PLoS One 2:e1188
Sznajder JI (2001) Alveolar edema must be cleared for the acute respiratory distress syndrome patient to survive. Am J Respir Crit Care Med 163:1293–1294
Sznajder JI, Ridge KM, Harris ZL, Olivera W, Curiel C, Rutschman DH (1994) Alveolar type II cell Na, K-ATPase is upregulated during mechanical ventilation-induced pulmonary edema. Chest 105:116S
Thaipadungpanit J, Wuthiekanun V, Chierakul W, Smythe LD, Petkanchanapong W, Limpaiboon R, Apiwatanaporn A, Slack AT, Suputtamongkol Y, White NJ, Feil EJ (2007) A dominant clone of Leptospira interrogans associated with an outbreak of human leptospirosis in Thailand. PLoS Negl Trop Dis 1:e56
Torgerson PR, Hagan JE, Costa F, Calcagno J, Kane M, Martinez-Silveira MS, Goris MG, Stein C, Ko AI, Abela-Ridder B (2015) Global burden of leptospirosis: estimated in terms of disability adjusted life years. PLoS Negl Trop Dis 9:e0004122
Truccolo J, Serais O, Merien F (2001) Following the course of human leptospirosis: evidence of a critical threshold for the vital prognosis using a quantitative PCR assay. FEMS Microbiol Lett 204:317–321
van Lookeren Campagne M, Wiesmann C, Brown EJ (2007) Macrophage complement receptors and pathogen clearance. Cell Microbiol 9:2095e102
Vadász I, Morty RE, Kohstall MG, Olschewski A, Grimminger F, Seeger W, Ghofrani HA (2005) Oleic acid inhibits alveolar fluid reabsorption: a role in acute respiratory distress syndrome? Am J Respir Crit Care Med 171:469–479
Verma A, Hellwage J, Artiushin S, Zipfel PF, Kraiczy P, Timoney JF, Stevenson B (2006) LfhA, a novel factor H-binding protein of Leptospira interrogans. Infect Immun 74:2659–2666
Verma A, Brissette CA, Bowman AA, Shah ST, Zipfel PF, Stevenson B (2010) Leptospiral endostatin-like protein A is a bacterial cell surface receptor for human plasminogen. Infect Immun 78:2053–2059
Vieira ML, Vasconcellos SA, Goncales AP, de Morais ZM, Nascimento AL (2009) Plasminogen acquisition and activation at the surface of leptospira species lead to fibronectin degradation. Infect Immun 77:4092e101
Vieira ML, Atzingen MV, Oliveira TR, Oliveira R, Andrade DM, Vasconcellos SA, Nascimento AL (2010) In vitro identification of novel plasminogen-binding receptors of the pathogen Leptospira interrogans. PloS One 5:e11259
Vieira ML, de Morais ZM, Vasconcellos SA, Romero EC, Nascimento AL (2011) In vitro evidence for immune evasion activity by human plasmin associated to pathogenic Leptospira interrogans. Microb Pathog 51:360–365
Vieira ML, Teixeira AF, Pidde G, Ching AT, Tambourgi DV, Nascimento AL, Herwald H (2018) Leptospira interrogans outer membrane protein LipL21 is a potent inhibitor of neutrophil myeloperoxidase. Virulence 9:414–425
Vijayachari P, Sugunan AP, Shriram AN (2008) Leptospirosis: an emerging global public health problem. J Biosci 33:557–569
Wang BO, Sullivan JA, Sullivan GW (1984) Role of specific antibody in interaction of leptospires with human monocytes and monocyte-derived macrophages. Infect Immun 46:809–813
Wang H, Wu Y, Ojcius DM, Yang XF, Zhang C, Ding S, Yan J (2012) Leptospiral hemolysins induce proinflammatory cytokines through Toll-like receptor 2-and 4-mediated JNK and NF-kappaB signaling pathways. PLoS One 7:e42266
Wolff DG, Castiblanco-Valencia MM, Abe CM, Monaris D, Morais ZM, Souza GO, Vasconcellos SA, Isaac L, Abreu PA, Barbosa AS (2013) Interaction of Leptospira elongation factor Tu with plasminogen and complement factor H: a metabolic leptospiral protein with moonlighting activities. PLoS One 8:e81818
Yamagata T, Yamagata Y, Nishimoto T, Hirano T, Nakanishi M, Minakata Y, Ichinose M, Dagenais A, Berthiaume Y (2009) The regulation ofamiloride-sensitive epithelial sodium channels by tumor necrosis factor-alpha in injured lungs and alveolar type II cells. Respir Physiol Neurobiol 166:16–23
Yang CW, Wu MS, Pan MJ, Hsieh WJ, Vandewalle A, Huang CC (2002) The Leptospira outer membrane protein LipL32 induces tubulointerstitial nephritis-mediated gene expression in mouse proximal tubule cells. J Am Soc Nephrol 13:2037–2045
Zipfel PF, Mihlan M, Skerka C (2007a) The alternative pathway of complement: a pattern recognition system. Adv Exp Med Biol 598:80e92
Zipfel PF, Wurzner R, Skerka C (2007b) Complement evasion of pathogens: common strategies are shared by diverse organisms. Mol Immunol 44:3850e7
Funding
This study was financially supported by the Long-Term Research Grant Scheme (LRGS) by the Ministry of Higher Education Malaysia (UPM/700-2/1/LRGS/5526400). They also provided infrastructure support for literature search.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
The authors declare that they have no conflicts of interest.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Chin, V.K., Basir, R., Nordin, S.A. et al. Pathology and Host Immune Evasion During Human Leptospirosis: a Review. Int Microbiol 23, 127–136 (2020). https://doi.org/10.1007/s10123-019-00067-3
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10123-019-00067-3